Dr. Jeffrey R. Jay, M.D. as of March 31, 2013
Portfolio Holdings for Dr. Jeffrey R. Jay, M.D.
Dr. Jeffrey R. Jay, M.D. holds 22 positions in its portfolio as reported in the March 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Hyperion Therapeutics | 24.7 | $23M | 894k | 25.82 | |
| Furiex Pharmaceuticals | 18.9 | $18M | 470k | 37.48 | |
| Vanda Pharmaceuticals (VNDA) | 9.0 | $8.4M | 2.1M | 3.92 | |
| OncoGenex Pharmaceuticals | 7.5 | $6.9M | 613k | 11.33 | |
| Pain Therapeutics | 6.2 | $5.8M | 1.7M | 3.43 | |
| Acelrx Pharmaceuticals | 5.3 | $5.0M | 966k | 5.16 | |
| D Horizon Pharma | 4.7 | $4.3M | 1.6M | 2.71 | |
| Biodel | 4.1 | $3.8M | 1.4M | 2.84 | |
| D Stemline Therapeutics | 3.7 | $3.4M | 300k | 11.41 | |
| Targacept | 3.5 | $3.3M | 761k | 4.28 | |
| EXACT Sciences Corporation (EXAS) | 2.5 | $2.3M | 238k | 9.81 | |
| Myriad Genetics (MYGN) | 1.9 | $1.8M | 70k | 25.41 | |
| Cardiovascular Systems | 1.9 | $1.7M | 85k | 20.48 | |
| Mei Pharma | 1.5 | $1.4M | 158k | 8.63 | |
| Oncothyreon | 1.4 | $1.3M | 606k | 2.08 | |
| Palatin Technologies | 1.3 | $1.2M | 2.0M | 0.60 | |
| ZIOPHARM Oncology | 0.8 | $737k | 403k | 1.83 | |
| NeoGenomics (NEO) | 0.7 | $603k | 153k | 3.94 | |
| Wright Med Group Inc right 03/01/2019 | 0.5 | $500k | 200k | 2.50 | |
| AVEO Pharmaceuticals | 0.1 | $94k | 13k | 7.34 | |
| RTI Biologics | 0.1 | $88k | 22k | 3.93 | |
| AMAG Pharmaceuticals | 0.0 | $4.0k | 150.00 | 26.67 |
